Team

All team members

Associate

Dr Sebastian Seufert

Associate

German Patent Attorney

Biologist

Sebastian is active in the wide field of the life sciences, including pharmaceuticals. He has specialized knowledge in the fields of molecular biology, genetics, pharmacology, immunology, biochemistry, plant protection products and food chemistry.

His main practice areas comprise procuring, defending, enforcing and challenging intellectual property rights in the above-mentioned fields.

In addition to advising clients on strategic issues in these technical fields, he drafts patent and utility model applications, conducts opposition and appeal proceedings before the EPO and prepares expert opinions on questions of freedom-to-operate, validity and infringement.

Sebastian earned his doctorate in interdisciplinary molecular biology and preclinical pharmaceutical research. In the course of his research, he investigated pharmacologically active substances for brain tumour treatments and analysed the molecular mechanisms of action involved. Several articles on this work have been published.

since 2022
Patent attorney at Maiwald
2018 - 2022
Patent attorney in a Munich IP firm
2015 - 2016
Patent attorney trainee in a Munich IP firm
2013 - 2015
Patent attorney trainee in a Düsseldorf IP firm
2012 - 2013
Research associate at the Coordination Centre for Clinical Trials (KKS), Düsseldorf University Hospital

2018
Admitted as a German patent attorney
2014 - 2016
Studied "Law for Patent Attorneys" at the Open University of Hagen”
2015
Trainee at Düsseldorf District Court, Patent Litigation Chamber 4c
2013
Studied "Patent Law for Engineers and Scientists", Beuth University of Applied Sciences (BHT) Berlin
2012
Full-time course "Clinical Research & Drug and Medical Device Approval" at mibeg-Institut Medizin, Cologne, Germany
2008 - 2011
Doctoral student in the interdisciplinary doctoral program in molecular medicine (IPMM), University Hospital, Cologne, Germany
2007 - 2011
Doctorate in biology in the field of preclinical pharmaceutical research on the therapy of malignant brain tumours at the Chair of Human Genetics of the University of Cologne in cooperation with the Chair of Neuropathology & Neurosurgery in Erlangen
2006 - 2007
Biology degree at the University of Cologne
2001 - 2006
Studied biology at the University of Cologne

  • Patent examination proceedings and portfolio management
  • Application strategies and drafting of patent applications
  • Freedom-to-operate- and validity opinions
  • Opposition and nullity proceedings
  • Patent litigation

  • Best Poster Award, 21st course in Medical Genetics, European School of Genetic Medicine, 2008, Bertinoro, Italy
  • Wilhelm Sander Foundation Scholarship
  • Scholarship from Cologne Fortune

  • Histone deacetylases inhibition by SAHA/Vorinostat normalizes the glioma microenvironment via xCT equilibration, Sci Rep, 2014 (together with Wolf IM et al.)

  • Deliverable 5.1: Report on regulations, privacy and security requirements, published within the framework of the project BioMedBridges, 2013 (together with Kuchinke W., et al.)

  • Deliverable 5.3: Legal and ethical issues regarding access to biobanks, published within the framework of the project p-medicine, 2013 (together with Forgó N., et al.)

  • Dissection of mitogenic and neurodegenerative actions of cystine and glutamate in malignant gliomas, Oncogene, 2011 (together with Savaskan NE, et al.)

  • PPAR Gamma Activators: Off-Target Against Glioma Cell Migration and Brain Invasion, PPAR Res., 2008 (together with Coras R., et al.)

  • German Patent Attorney Association

  • German
  • English